MENU
BRNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Barinthus Biotherapeutics (BRNS) Ownership - Who owns Barinthus Biotherapeutics?
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer... Show more
Profile
Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
42.36M
P/E Ratio
N/A
Total Cash
106.1M
Projected Growth
N/A
Total Debt
12.67M
Revenue
14.97M
Risk (Beta)
-1.02
Dividend Yield
N/A
Total Cash/Share
2.63
Total Debt/Equity
N/A
Revenue/Share
0.38 USD as % of share price
Fundamentals
BRNS
Capitalization
42.4M
P/E Ratio
N/A
Risk (Beta)
-1.02
Dividend Yield
N/A
Total Cash
106M
Total Cash/Share
2.63
Total Debt
12.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.38%
Revenue
15M
ROE
N/A
Book Value
159M
P/B Ratio
0.33
Cash Flow
N/A
Earnings
-1.49
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
8.93
Current Revenue Per Employee
115146.16
Dividends Per Share - Security
N/A
EBITDA
-52.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.62
Shares Held By Institutions
9.73M
Shares Outstanding - Current
40.3M
Total Liabilities
29.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-13.079
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com